Delaying Bone Drugs After Cancer Spreads to Bone Nearly Doubles Fracture Risk, Study Finds
A retrospective landmark and propensity score–matched analysis found that delaying bone-modifying agent therapy beyond six months after a bone metastasis ...
A retrospective landmark and propensity score–matched analysis found that delaying bone-modifying agent therapy beyond six months after a bone metastasis ...
A nationwide Finnish registry study of 652 breast cancer patients with bone metastases found jawbone necrosis in 12.6 percent of ...
A multicentre proteomics study finds that patients with medication-related osteonecrosis of the jaw have significantly reduced circulating dopamine β-hydroxylase, linking ...
A 48-week prospective cohort study finds that switching men with HIV off tenofovir disoproxil fumarate to TAF-based or tenofovir-free regimens, ...
A new cohort study finds that only 6 percent of treatment-naive patients hospitalized with non-traumatic fractures receive antifracture medications, yet ...
A nationwide Finnish cohort study found that people with Parkinson's disease receive anti-osteoporosis medications at rates similar to or higher ...
A new translational study shows that adding RANKL inhibition to lutetium-177-labeled bisphosphonate radioligand therapy stabilizes the bone microenvironment and sharply ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine